Rachit Singla
Rachit Singla

Director - Life Sciences

About Rachit Singla
Expertise
Life Sciences Pharma & Biotech Consumer Health Medical Technology Sustainability Business Development
Highlights
  • Life sciences and consumer health leader.
  • Trusted partner to global teams driving innovation and growth.
  • Focused on practical solutions rooted in science and market reality.
  • Committed to building strong partnerships and high-performing teams.
  • Curious by nature. Driven by purpose.
With over 15 years of experience in business development, consulting, and strategic insights, Rachit Singla leads the Life Sciences practice at FutureBridge. He partners with global life sciences, pharma, biotech, and consumer health companies to navigate disruption, identify emerging technologies, and drive sustainable growth. Rachit specializes in connecting R&D, commercialization, and foresight to help organizations future-proof portfolios and accelerate innovation pipelines. His leadership has been pivotal in building long-term client partnerships and delivering measurable outcomes through disruption monitoring, horizon planning, and opportunity mapping. He brings deep cross-sector experience across life sciences, medical technology, nutrition, and healthcare, and is known for fostering collaboration, mentoring high-performance teams, and driving purpose-led innovation that delivers business impact.

Advancing Life Sciences

"The next era of life sciences will be defined by convergence - where science, data, and sustainability meet. I’m committed to helping organizations turn that convergence into actionable strategies that accelerate innovation and improve lives globally."

- Rachit Singla

Publications and Videos

FutureBridge_what are biomaterials

What Are Biomaterials?

Executive Report

Biomaterials Insight | Strategic Primer What are biomaterials and why does material class selection matter so much in medical devices?...
FutureBridge_Biomaterials

How can your Biomaterial Innovation achieve commercial viability?

Executive Report

The Biomaterials Market Has Crossed $200 Billion. The Real Question Is: Which Innovations Will Actually Scale? Biomaterials are entering a...
FutureBridge_GLP-1 is creating a new skin baseline

The GLP-1 Body Reset: Why the Beauty Industry’s Window to Act Is Rapidly Closing

Article

100M+ Projected global GLP-1 users by 2030, from fewer than 15M today 22% Average body weight reduction on tirzepatide over...
FutureBridge_Surgical robot in operating room showing cost impact and ROI for MedTech healthcare systems

Do Surgical Robotics Reduce Healthcare Costs or Add to Them?

Article

No procurement committee, hospital CFO, or R&D leadership team has fully cracked this question yet. When a surgical robot rolls...

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.